This biotech’s stock rockets on oral obesity drug partnership with Wegovy parent

3 months ago 11
ARTICLE AD BOX
Novo Nordisk looks to harness Septerna’s broader GPCR drug pathways, which include GLP-1, for obesity and diabetes treatments.
Read Entire Article
  1. Homepage
  2. Finance
  3. This biotech’s stock rockets on oral obesity drug partnership with Wegovy parent

Related

Home-builder stocks are hot — these are expected to show the best growth numbers

Home-builder stocks are hot — these are expected to show the...

16 minutes ago 0
The bull case for Nvidia just got stronger, according to these Wall Street analysts

The bull case for Nvidia just got stronger, according to the...

25 minutes ago 0
Is Nvidia a Republican or a Democrat? These political ETFs have voted.

Is Nvidia a Republican or a Democrat? These political ETFs h...

1 hour ago 0

Trending

1. nfl crocs
2. baseball
3. durango high school
4. leeds united vs everton f.c. timeline
5. gerard butler
6. julian sayin
7. hailey baptiste
8. lausd
9. lois boisson
10. times square

Popular

Netflix scuttles plans to add six previously announced games to its service

Netflix scuttles plans to add six previously announced games...

6 months ago 264
Can Pidcock win big & why did it end at Ineos?

Can Pidcock win big & why did it end at Ineos?

5 months ago 233
Steam will label early access games that haven't been updated in a year

Steam will label early access games that haven't been update...

6 months ago 222
OpenAI co-founder John Schulman has left Anthropic after less than a year

OpenAI co-founder John Schulman has left Anthropic after les...

6 months ago 221
Google's Magic Editor will watermark its AI-tweaked photos

Google's Magic Editor will watermark its AI-tweaked photos

6 months ago 210
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Nexa News 2025. All rights are reserved